<DOC>
	<DOCNO>NCT02307279</DOCNO>
	<brief_summary>This study asses decrease body weight repeat administration Gelesis100 overweight obese subject without Type 2 Diabetes .</brief_summary>
	<brief_title>Study Gelesis100 Body Weight Overweight Obese Subjects With Without Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<criteria>Age 22 65 year age , inclusive Signed Informed Consent Form BMI 27 40 , inclusive ( BMI &lt; 30 least one comorbidity ) Fasting plasma glucose 90mg/dL 145 mg/dL , inclusive ; nondiabetic normoglycemic ( fast glucose 90 mg/dL 100 mg/dL , inclusive ) ; nondiabetic impair fast glucose 100mg/dL 126 mg/dL ; diabetic : untreated ( 126 mg/dL 145 mg/dL , inclusive ) metformintreated ( metformin dose 1500mg/DL less , fast glucose less 145 mg/dL , inclusive ) Pregnancy lactation Absence medically approve contraceptive method female childbearing potential History allergic reaction modify cellulose , citric acid , sodium stearyl fumarate , raw cane sugar , gelatin , titanium oxide Administration investigational product within 1 month prior Screening Visit Subjects stop smoke within 6 month prior Screening Visit consider smoke cessation study Subjects anticipate surgical intervention study Known Type 1 diabetes History eat disorder Angina , coronary bypass , myocardial infarction within 6 month prior Screening Visit History : swallowing disorder , esophogeal anatomic abnormality , gastroesophageal reflux disease , gastric duodenal ulcer , gastroparesis ( chronic nausea , vomit , heartburn ... ) , gastric bypass gastric surgery , intestinal obstruction high risk include suspect small bowel adhesion , pancreatitis , malabsorption , history bowel resection ( except relate appendectomy ) , history abdominal radiation treatment Laxative user History : HIV , hepatitis B C ; cancer within past 5 year Abnormal serum thyroidstimulating hormone ( TSH ) Positive urine drug test Antiobesity medication within 1 month prior Screening Visit ( except stable dos metformin , 1500 mg/day , leaset 1 month subject type 2 diabetes ) Systemic corticosteroid within 1 month prior Screening Visit Thyroid hormone preparation within 1 month prior Screening Visit Estrogen within 1 month prior Screening Visit Any medication know cause weight loss weight gain within 1 month prior Screening Visit TSH suppression therapy thyroid cancer medication require mandatory administration meal ( lunch dinner ) , except metformin Other medication product use chronic disease impair gastrointestinal absorption cause safety issue Change medication treat hypertension and/or dyslipidemia within 1 month prior Screening Visit ( include change dose ) Anticipated requirement use prohibit concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>